Meditech International Incorporated

 

Mission Statement:

Meditech International Incorporated initiated research into the development of Low Intensity Laser Therapy (LILT) Systems in 1989. Our primary objective has always been to significantly improve/cure the multiple pathologies that we encounter in the shortest possible period of time. Meditech’s mission consists of the elimination of pain, reduction in the use of pharmaceuticals, the restoration of normal mobility and quality of life.

Executive Summary:

The company was founded by Fred Kahn, M.D., FRCS(C), whose vision was to develop and manufacture superior Low Intensity Laser Therapy Systems. The synergy developed between the disciplines of engineering and clinical medicine has allowed us to achieve those objectives. Our product line continues to become diversified in order to deliver therapy at multiple levels and has been characterized as the “New Dimension in Medicine.” At our rehabilitation clinics, which administer over 800 treatments each week, we continue to develop new protocols in order to improve and widen the application of the therapy. BioFlex systems are operative in over 34 countries worldwide and have been termed the gold standard in the industry. The company continues to extend the applications of the therapy and create more comprehensive educational programs. In addition to the clinical studies that we conduct, we host Certification Courses, Advanced Seminars and International Symposia, in a variety of formats. Educational programs are now held on an almost weekly basis.

• Patient Brochure.

• Practitioner Brochure.

• Certification Dates 2008.

• Product Catalogue.

 

Contact:

 

Fred Kahn, M.D., F.R.C.S.

President

E-mail: info@meditech-bioflex.com

Website: www.meditech-bioflex.com